Business Wire

OK-OSU

16.12.2021 14:02:09 CET | Business Wire | Press release

Share
Historic Donation Establishes Hamm Institute for American Energy at Oklahoma State University

The Harold Hamm Foundation and Continental Resources announced today a combined $50 million gift creating the Hamm Institute for American Energy at Oklahoma State University.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211215006096/en/

The Hamm Institute’s mission is to educate the next generation of energy leaders — in Oklahoma, the United States and from around the world — cementing Oklahoma’s legacy as a global energy leader.

“The generous gifts from Harold Hamm and Continental Resources to establish the Hamm Institute for American Energy will have a transformative impact on OSU and the energy sector worldwide. With a state-of-the art lab featuring wells drilled below the building, an auditorium, and classrooms, this building is fit for purpose,” OSU President Kayse Shrum said. “Mr. Hamm’s and Continental’s generosity will bring together the brightest minds and future energy sector leaders from around the world, all with a goal of solving one of society’s most pressing concerns. Together, we will change the trajectory of energy security in the United States.”

The initial funding for the institute and project will be a gift of $50 million dollars — $25 million from the Harold Hamm Foundation and $25 million from Continental Resources. The Hamm Institute will be located in what was formerly known as OSU Discovery, 300 NE 9th St. in the Oklahoma City Innovation District, and will become the primary and permanent occupant of the building.

The Hamm Institute will become the center of all things American energy. It will host symposiums, authors, speakers, energy summits and global energy leadership conversations. The building will eventually house the Oklahoma Hall of Energy Legends Interactive Museum, a public exhibit highlighting the history and storied legacy of Oklahoma’s great energy leaders.

Hamm, a native Oklahoman and founder and chairman of Continental Resources, began his career in oil and gas over five decades ago, starting out with a single oil service truck and a dream. His incredible journey, entrepreneurial spirit and will to change the world for the better have inspired countless others, and his latest philanthropic push aims to elevate the state to both new and familiar heights.

Hamm is recognized as a national leader and staunch advocate of America’s domestic oil and natural gas industry. He has spent over five and a half decades in the industry, from starting his own oil services business to founding one of America’s most dynamic and innovative exploration and production companies, Continental Resources. His efforts have contributed to the well-being of every American and are helping secure the nation’s energy and economic security. The Hamm Institute will ensure America leads the world when it comes to advancing innovation and technology while responsibly producing the energy we need for decades to come.

“It’s time, once again, for Oklahoma to become a global energy leader. It’s my hope the world will look to us for the best ideas when it comes to energy stewardship, research, and education. This gift is about investing in our shared future — the future of our country and the state and people I love,” Hamm said. “I see the Institute as a game changer — a place where the best and the brightest will come together to responsibly solve the world’s energy challenges. A third of the world lives in energy poverty. We need to fix that. And we need to make sure Americans will always have an abundance of reliable, affordable energy for generations to come.”

“Oklahoma is an energy state and Harold is our energy icon. This collaboration between one of our great universities and one of our most innovative and successful energy companies and entrepreneurs will raise the bar for American energy innovation,” said Oklahoma Gov. Kevin Stitt.

In acknowledgement of Continental’s contributions, the building’s concourse and auditorium will be named as the Continental Resources Concourse and Continental Resources Auditorium. The program fund supporting the institute also will be named in recognition of Continental.

“The Hamm Institute belongs here in Oklahoma. It is part of the Continental mission – to find, nurture and inspire the next generation of energy leaders. We envision the Hamm Institute for American Energy to be the epicenter of learning, research and energy innovation for decades to come,” said Bill Berry, Continental Resources CEO.

P​​HOTOS/VIDEO: A multimedia package including b-roll, soundbites and photos is available for media use here: okla.st/hamm .

REBROADCAST: View the rebroadcast of this announcement at insideosu.com .

Oklahoma State University is a modern land-grant university that prepares students for success. OSU has more than 34,000 students across its five-campus system and more than 24,000 on its combined Stillwater and Tulsa campuses, with students from all 50 states and around 100 nations. Established in 1890, OSU has graduated more than 275,000 students to serve the state of Oklahoma, the nation and the world.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye